title: Alpha1,3fucosyltransferases in cystic fibrosis airway epithelial cells.
abstract: Cystic fibrosis (CF) has a glycophenotype of aberrant sialylation and/or fucosylation. The CF glycophenotype is expressed on membrane glycoconjugates of CF airway epithelial cells as increased fucosyl residues in alpha1,3/4 linkage to N-acetyl glucosamine, decreased fucosyl residues in alpha1,2 linkage to galactose and decreased sialic acid. To define the cause of this phenotype, the enzyme activity of alpha1,3fucosyltransferase (FucT) was examined in extracts of CF airway epithelial cells with a variety of low molecular weight substrates. Using Galbeta1,4GlcNAc as substrate, the activity was divided into 66% alpha1,3FucT and 34% alpha1,2FucT. mRNA expression examined with probes to FucTIII, IV, and VII showed that the highest expression of two CF cell lines was for FucTIV. Only one CF cell line expressed mRNA for FucTIII. The non CF airway epithelial cells had significant enzyme activity for alpha1,3FucT and strong mRNA expression for FucTIV. Thus as reported previously for alpha1,2FucT, the biochemical capacity for alpha1,3FucT was present in both the CF and non CF cells and can not be the cause of the CF glycophenotype. These results support the hypothesis that wild type CFTR acts in the Golgi and when mutated as in CF, faulty compartmentalization of terminal glycosyltransferases results, yielding the CF glycophenotype.
authors.affiliation: The Cystic Fibrosis Center and Department of Pediatrics, University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia, 19104-4318, USA.
authors.forename: Lidia I
authors.initials: LI
authors.lastname: Stoykova
authors.forename: Aihua
authors.initials: A
authors.lastname: Liu
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Scanlin
authors.forename: Mary Catherine
authors.initials: MC
authors.lastname: Glick
mesh_terms: D002240:Carbohydrate Sequence; D002460:Cell Line; D003550:Cystic Fibrosis / Q000201:enzymology* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism; D004847:Epithelial Cells / Q000201:enzymology; D005647:Fucosyltransferases / Q000235:genetics / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D009844:Oligosaccharides / Q000737:chemistry / Q000378:metabolism; D010641:Phenotype; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012137:Respiratory System / Q000201:enzymology*; D013379:Substrate Specificity; D000097631:Galactoside 2-alpha-L-fucosyltransferase
chemical_list: D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D005647:Fucosyltransferases; D009844:Oligosaccharides; D012333:RNA, Messenger; D000097631:Galactoside 2-alpha-L-fucosyltransferase; C505032:CFTR protein, human; C031692:galactoside 3-fucosyltransferase